Tango Therapeutics TNGX Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's common stock, shares authorized (in shares)?
- Tango Therapeutics (TNGX) reported common stock, shares authorized (in shares) of $400M in Q1 2026.
- How has Tango Therapeutics's common stock, shares authorized (in shares) changed year-over-year?
- Tango Therapeutics's common stock, shares authorized (in shares) increased by 100.0% year-over-year, from $200M to $400M.
- What is the long-term trend for Tango Therapeutics's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Tango Therapeutics's common stock, shares authorized (in shares) has grown at a 28.8% compound annual growth rate (CAGR), from $56.39M to $200M.